Patent application number | Description | Published |
20090012060 | Antitumor Agent - The present invention provides an antitumor agent and the like, which comprises as an active ingredient, a pyrimidine derivative represented by Formula (I): | 01-08-2009 |
20090042883 | ANTITUMOR AGENT - The present invention provides a therapeutic agent for a tumor selected from a hematopoietic tumor and a solid tumor which comprises, as an active ingredient, a benzoyl compound represented by General Formula (I): | 02-12-2009 |
20090082348 | INDAZOLE DERIVATIVES - The present invention provides a compound represented by Formula (I): | 03-26-2009 |
20090209537 | AURORA INHIBITORS - The present invention provides an Aurora inhibitor which comprises, as an active ingredient, an indazole derivative represented by Formula (I) (wherein R | 08-20-2009 |
20090247522 | Hsp90 FAMILY PROTEIN INHIBITORS - The present invention provides Hsp90 family protein inhibitors comprising, as an active ingredient, a benzoyl compound represented by general formula (I): | 10-01-2009 |
20100098690 | PHARMACEUTICAL COMPOSITION - The present invention provides a pharmaceutical composition comprising a combination of an Hsp 90 family protein inhibitor and at least one compound, the said pharmaceutical composition wherein the Hsp 90 family protein inhibitor is a benozoyl compound represented by formula (I): | 04-22-2010 |
20100104567 | PHARMACEUTICAL COMPOSITION - The present invention provides a pharmaceutical composition comprising a combination of an Flt-3 inhibitor and at least one compound, the said pharmaceutical composition wherein an Flt-3 inhibitor is an indazole derivative represented by Formula (I) | 04-29-2010 |
20110112099 | THERAPEUTIC AGENT FOR CANCER RESISTANT TO PROTEASE INHIBITOR - The present invention provides therapeutic agents for a cancer resistant to a protease inhibitor which comprises, as an active ingredient, a benzoyl compound represented by formula (I): | 05-12-2011 |
20120329794 | Ab1 KINASE INHIBITORS - The present invention provides an Abelson kinase (Abl kinase) inhibitor which comprises, as an active ingredient, an indazole derivative represented by Formula (I) (wherein R | 12-27-2012 |